Welcome to our dedicated page for Cabot SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cabot Corporation (NYSE: CBT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a global specialty chemicals and performance materials company, Cabot uses its SEC filings to report financial performance, segment results for Reinforcement Materials and Performance Chemicals, risk factors, sustainability information and corporate governance matters.
Investors can review Cabot’s annual reports on Form 10-K and quarterly reports on Form 10-Q to see detailed discussions of net sales, earnings, segment EBIT, regional volume trends and cash flows, along with commentary on demand conditions in the Americas, Europe, the Middle East and Africa, and Asia Pacific. These filings also describe key product areas such as reinforcing carbons, specialty carbons, battery materials, fumed metal oxides, inkjet colorants, masterbatches and conductive compounds, engineered elastomer composites and aerogel.
Cabot’s current reports on Form 8-K disclose material events, including the release of quarterly operating results, agreements such as the planned acquisition of Mexico Carbon Manufacturing S.A. de C.V. from Bridgestone Corporation, supply arrangements for battery materials and changes in board composition. Form 8-K filings also reference earnings press releases that provide non-GAAP measures like Adjusted EPS, Total Segment EBIT and Adjusted EBITDA, along with reconciliations to GAAP metrics.
Through Stock Titan, users can track Cabot’s real-time filing activity from EDGAR and use AI-powered summaries to interpret complex documents. These summaries highlight key points from lengthy 10-K and 10-Q filings, explain the significance of non-GAAP measures and clarify disclosures about segment performance, sustainability initiatives and capital allocation. The filings page also helps users locate proxy materials and insider transaction reports on Form 4, which provide additional context on executive and director roles, equity-based compensation and share ownership changes.
By consolidating Cabot’s SEC filings with AI-generated insights, this page supports users who want to understand how the company reports on its reinforcing carbons and performance chemicals businesses, evaluates risks and opportunities, and communicates with regulators and investors.
Cabot Corporation director Michael M. Morrow reported an acquisition of company common stock under a director compensation arrangement. On January 8, 2026, he acquired 2,298 shares of Cabot common stock at a reported price of $0 per share, reflecting stock granted rather than purchased for cash. Following this transaction, he beneficially owned 22,302 shares of Cabot common stock in direct form.
The filing notes that these shares have been deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning the value is credited for the director’s benefit instead of being immediately delivered in standard shares. The transaction reflects routine director equity compensation rather than an open-market trade.
Cabot Corporation director Christine Y. Yan reported receiving 2,298 shares of Cabot common stock on January 8, 2026, as an acquisition transaction. The shares were credited at a price of $0.00 per share under Cabot's Non-Employee Directors' Deferral Plan, meaning they represent deferred director compensation rather than an open-market purchase. Following this transaction, Yan beneficially owned 17,171 shares of Cabot common stock in direct form. This filing reflects routine equity-based compensation for a non-employee director rather than a cash trade in the stock.
Cabot Corporation director Frank Anders Wilson reported an acquisition of company stock under a deferred compensation arrangement. On January 8, 2026, he acquired 2,298 shares of Cabot common stock at a stated price of $0 per share, bringing his directly held beneficial ownership to 18,552 shares. The filing explains that these shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan, meaning the award is tied to his service as a non-employee director rather than an open-market purchase.
Cabot Corporation director Cynthia A. Arnold reported acquiring additional company stock. On January 8, 2026, she acquired 2,298 shares of Cabot common stock in a transaction reported with a price of $0 per share, indicating the shares were received without cash payment, such as through an award or similar arrangement. Following this transaction, she beneficially owns 19,620 shares of Cabot common stock, held directly in her name.
Cabot Corporation director William C. Kirby reported an acquisition of 486 shares of Cabot common stock on January 8, 2026, at a price of $0 per share. These shares were acquired as a form of compensation rather than through an open-market purchase, and are linked to Cabot's Non-Employee Directors' Deferral Plan. Following this transaction, Kirby beneficially owned 27,688 shares of Cabot common stock in direct form.
The filing characterizes this as a non-derivative, compensation-related award, reflecting ongoing equity-based alignment between the director and the company.
Cabot Corporation director Raffiq Nathoo filed an amended insider report updating his holdings of cash-settled phantom stock units tied to Cabot common stock. On 12/31/2025, he reported the disposition of 3,383.8519 phantom stock units referencing the same number of Cabot common shares at $66.28 per share, in line with his distribution election under the Non-Employee Director's Deferral Plan. He also reported acquiring 358.3283 additional phantom stock units on the same date at $66.28, bringing his directly held phantom stock balance to 1,284.065 units. These phantom units are paid in cash and are designed to mirror the value of Cabot’s stock rather than representing actual shares.
Cabot Corporation director reports additional phantom stock units. Director Juan Enriquez filed a statement covering a transaction dated 12/31/2025. He acquired 414.9064 phantom stock units linked to Cabot Corporation common stock at a reference price of $66.28 per unit. After this transaction, he beneficially owned 55,404.8891 phantom stock units in a direct capacity. Each phantom stock unit represents a 1-for-1 economic interest in a share of common stock, and the units will be settled in cash either when he ceases serving as a director or according to his prior distribution election, whichever occurs first.
Cabot Corporation director Raffiq Nathoo reported an equity-related compensation transaction dated 12/31/2025. The filing shows the acquisition of 358.3283 phantom stock units, coded as an "A" (acquired) transaction, with a reference price of $66.28 per unit.
Following this transaction, Nathoo beneficially owns 1,284.065 phantom stock units on a direct basis. Each phantom stock unit is subject to a 1-for-1 relationship with Cabot common stock. The phantom stock will be settled in cash either when Nathoo’s service as a director ends or in line with his distribution election, whichever occurs first.
Cabot Corporation officer reports phantom stock grant under benefit plan
A Cabot Corporation executive, serving as VP, Controller & CAO, reported the acquisition of derivative equity-based compensation tied to Cabot common stock. On 12/31/2025, the reporting person received 182.3206 phantom stock units, each linked on a 1-for-1 basis to a share of Cabot common stock at a reference price of $66.28. Following this grant, the executive beneficially owned 733.9176 phantom stock units in total.
The phantom stock units were acquired under Cabot’s supplemental 401(k) plan and are scheduled to be settled in Cabot common stock when the executive retires or otherwise terminates service, rather than being settled immediately.
Cabot Corporation senior vice president and general counsel Karen A. Kalita reported an insider equity transaction involving derivative securities. On 12/31/2025, she acquired 922.4094 phantom stock units tied to Cabot common stock at a price of $66.28 per unit. Each phantom unit represents a 1-for-1 claim on a share of common stock and was granted under the company’s supplemental 401(k) plan, to be settled when she retires or otherwise leaves the company. Following this transaction, she beneficially owns 5,247.3392 phantom stock units directly.